Terms: = Uterine cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Diagnosis
7 results:
1. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.
da Costa LT; Dos Anjos LG; Kagohara LT; Torrezan GT; De Paula CAA; Baracat EC; Carraro DM; Carvalho KC
Clinics (Sao Paulo); 2021; 76():e2324. PubMed ID: 33503190
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Initiating Screening Programs on Referral and Management of Cervical cancer in Tanzania.
Sedani A; Soliman AS; Msami K; Msemo D; Mwaiselage J; Schmid K; Kahesa C
J Glob Oncol; 2019 Jul; 5():JGO1800052. PubMed ID: 31343933
[TBL] [Abstract] [Full Text] [Related]
3. Rare myeloid sarcoma with kmt2a (mll)-ELL fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study.
Acera A; Manresa JM; Rodriguez D; Rodriguez A; Bonet JM; Sanchez N; Hidalgo P; Soteras P; Toran P; Trapero-Bertran M; Lozano I; De Sanjose S
BMC Womens Health; 2014 Jul; 14():86. PubMed ID: 25026889
[TBL] [Abstract] [Full Text] [Related]
5. Feasibility and outcome of laser CO2 conization performed within the 18th week of gestation.
Fambrini M; Penna C; Fallani MG; Pieralli A; Mattei A; Scarselli G; Taddei GL; Marchionni M
Int J Gynecol Cancer; 2007; 17(1):127-31. PubMed ID: 17291242
[TBL] [Abstract] [Full Text] [Related]
6. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
[TBL] [Abstract] [Full Text] [Related]
7. Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21; q23): mll rearrangement, p53 mutation and multilineage involvement.
Bigoni R; Cuneo A; Roberti MG; Moretti S; De Angeli C; Dabusti M; Campioni D; del Senno L; Biondi A; Chaplin T; Young BD; Castoldi G
Leukemia; 1999 May; 13(5):704-7. PubMed ID: 10374873
[TBL] [Abstract] [Full Text] [Related]
